Click for next page ( 259

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 258
Appendix B Steering Committee Bios Coenraad F.M. Hendriksen, DVM, PhD, Chair, is Head of the Netherlands Centre for Alternatives to Animal Use, Chair of the Alternatives to Animal Use at the Veterinary Faculty of Utrecht University, and Senior Scientist at the Labo- ratory for the Quality Control of Biologicals, Central Animal Laboratories (RIVM). His expertise is in animal welfare concerns and lab animal issues in Europe. His research activities are focused on the development and validation of methods to replace, reduce, and/or refine the use of laboratory animals, espe- cially in the field of the production and quality control of immunobiologicals. He is coeditor of several books and congress proceedings. At the time of the workshop he was a member of the Central Committee on Animal Experimenta- tion (CCD) in the Netherlands, chair of the ECVAM Steering Group on Biologi- cals, and a member of the Institute for Laboratory Animal Research (ILAR) Council (2002–2008). He also served on the steering committee for the 2003 ILAR International Workshop on Science-Based Guidelines for Laboratory Animal Care. Stephen W. Barthold (IOM), DVM, is Distinguished Professor of Veterinary and Medical Pathology at the University of California, Davis, and Director of the UC Davis Center for Comparative Medicine. His professional specialty is infectious diseases of laboratory rodents and biology of the laboratory mouse, with a primary focus on pathogenesis of Lyme borreliosis for the last 25 years. Dr. Barthold was elected to the Institute of Medicine (IOM) in 2001 and has received a number of career awards. He has served on numerous national scien- tific advisory and review committees and published over 300 peer-reviewed articles, chapters, and books. Dr. Barthold was a member of the steering com- mittee for the 2003 ILAR workshop and a member (2002–2005) and then Chair (2005–2011) of the ILAR Council. 258

OCR for page 258
Appendix B 259 Kathryn A. Bayne, MS, PhD, DVM, DACLAM, CAAB, is Global Director for the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC International). In this role she directs the accreditation program worldwide and travels extensively to advance AAALAC’s accredita- tion program and laboratory animal welfare. Prior to this position she worked at the National Institutes of Health leading a research program on nonhuman pri- mate psychological well-being and environmental enrichment programs for pri- mates, dogs, cats, and swine. She has published over 40 articles on the subject and has also published extensively on accreditation of laboratory animal care and use programs. Dr. Bayne is a charter member and part of the Executive Team of the International Association of Colleges of Laboratory Animal Medi- cine (IACLAM). She has been a member of the ILAR Council since 2006 and also served on the NRC committees that prepared reports on the Psychological Well-Being of Nonhuman Primates, Occupational Health and Safety in the Care of Nonhuman Primates, and Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. Jeffrey Everitt, DVM, is Director of Comparative Medicine and Investigator Support at GlaxoSmithKline (GSK) Research & Development in Research Tri- angle Park, North Carolina. Dr. Everitt spent 17 years on the senior scientific staff of the CIIT Centers for Health Research in Research Triangle Park before joining GSK’s global Laboratory Animal Sciences department. He is also an adjunct faculty member in the Department of Pathology and Laboratory Medi- cine at the University of North Carolina School of Medicine in Chapel Hill and at the North Carolina State University College of Veterinary Medicine. He served on the ILAR Council (2004–2010) and on the Board of Directors of the American College of Laboratory Animal Medicine. He is a diplomate of the American College of Veterinary Pathologists and of the American College of Laboratory Animal Medicine, as well as a Fellow of the International Academy of Toxicological Pathology. James G. Fox (IOM), DVM, is Director of the Division of Comparative Medicine and a professor in the Department of Biological Engineering at the Massachusetts Institute of Technology as well as an Adjunct Professor at Tufts University School of Veterinary Medicine and the University of Pennsylvania School of Veterinary Medicine. He is a Diplomate and past president of the American College of Laboratory Animal Medicine. Professor Fox is the author of over 525 articles, 80 chapters, and 4 patents and has edited and authored 13 texts in the field of in vivo model development and comparative medicine. He has given over 250 invited lectures, consults nationally and internationally with government, academia, and industry, and has served on several journal editorial boards. He has been the principal investigator of an NIH postdoctoral training

OCR for page 258
260 Animal Research in a Global Environment: Meeting the Challenges grant for veterinarians for the past 23 years and has trained 50 veterinarians for careers in biomedical research. He also has an NIH training grant for veterinary students and has introduced over 100 veterinary students to careers in biomedi- cal research. He is a past member of the NIH/NCRR Scientific Advisory Coun- cil and of the ILAR Council (2005–2011). Joseph W. Kemnitz, PhD, is Director of Translational Technologies and Re- sources at the Institute of Clinical and Translational Research and professor in the Department of Cellular and Regenerative Biology at the University of Wis- consin, Madison. Until recently he was based at the National Primate Research Center and served as its director from 1996 to 2010. Prior to that he was a mem- ber and chair of the IACUC for the Graduate School. His research has focused on nutrition and metabolism in the contexts of reproductive physiology and ag- ing, primarily using rhesus macaques. He was a member of the ILAR Council from 2005 to 2011. Hilton J. Klein, VMD, MS, is former Senior Director for Comparative Medi- cine at Merck Research Laboratories. He was also an adjunct assistant professor in the Department of Laboratory Animal Resources at the University of Penn- sylvania. His research interests are in laboratory animal science, particularly in the field of laboratory animal infectious disease and surgical production of ani- mal models. He served as a consultant to the Pan American Health Organization as Merck’s representative on nonhuman primate conservation. He was a member of the steering committee of the 2003 workshop and of the ILAR Council (1998–2005). Judy A. MacArthur Clark, CBE, BVMS, DVMS, DLAS, DipECLAM, DACLAM, FSB, FRAgS, is Chief Inspector in the Animals Scientific Proce- dures Inspectorate of the Home Office in London, United Kingdom. From 2005 to 2007 she was Vice President of Worldwide Comparative Medicine at Pfizer in Groton, Connecticut, and before that (1992–2005) served as Director of Mar- keting and Sales at BioZone Ltd., which she cofounded. For over 20 years she has consulted on ethical policy development and improving public understand- ing of science. She is a member and former President of the UK Royal College of Veterinary Surgeons and has chaired or served as a member of many high- level national and international advisory committees on topics such as xeno- transplantation, farm animal welfare, research funding priorities, and bioethics. She actively works on research regulation and policy development in the United Kingdom, Europe, and the United States. She is a member of the ILAR Council (2006–2012).